Cochlear (COHN) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

COHN Analyst Ratings

Hold

0 Buy

6 Hold

1 Sell

Based on 7 analysts giving stock ratings to

Cochlear

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

COHN Stock 12 Month Forecast

Average Price Target

$1,425.50

▼(-40.39% Downside)

Based on 7 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is $1,425.50 with a high forecast of $1,612.96 and a low forecast of $1,212.75. The average price target represents a -40.39% change from the last price of $2,391.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1211":"$1,211","3202":"$3,202","1708.75":"$1,708.8","2206.5":"$2,206.5","2704.25":"$2,704.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1612.96190762,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.61K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1425.5048953702858,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.43K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1212.753314,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.21K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1211,1708.75,2206.5,2704.25,3202],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2391.38,2331.5016852015387,2271.623370403077,2211.7450556046156,2151.8667408061538,2091.9884260076924,2032.1101112092308,1972.2317964107692,1912.3534816123076,1852.475166813846,1792.5968520153847,1732.7185372169229,1672.8402224184615,{"y":1612.96190762,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2391.38,2317.0819150284838,2242.783830056967,2168.4857450854506,2094.1876601139343,2019.8895751424177,1945.5914901709011,1871.2934051993848,1796.9953202278682,1722.6972352563516,1648.3991502848353,1574.1010653133187,1499.8029803418021,{"y":1425.5048953702858,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2391.38,2300.716408769231,2210.0528175384616,2119.3892263076923,2028.725635076923,1938.0620438461538,1847.3984526153847,1756.7348613846154,1666.0712701538462,1575.407678923077,1484.7440876923076,1394.0804964615386,1303.4169052307693,{"y":1212.753314,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3175.592,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3175.592,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3175.592,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3201.399,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3201.399,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3201.399,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3201.399,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3201.399,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2364.349,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2391.38,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2391.38,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2391.38,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2391.38,"date":1782864000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,613

Average Price Target$1,426

Lowest Price Target$1,213

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Stanton

Jefferies

$1,557.18

Hold

-34.88%

Downside

Downgraded

07/28/26

Cochlear (CHEOF) was downgraded to a Hold Rating at Jefferies

Chris Cooper

J.P. Morgan

$1,346.16→$1,448.03

Hold

-39.45%

Downside

Reiterated

07/21/26

Cochlear (CHEOF) Receives a Hold from J.P. Morgan

Craig Wong-Pan

RBC Capital

$1,515.94→$1,418.92

Hold

-40.67%

Downside

Downgraded

07/16/26

RBC Capital downgrades Cochlear (CHEOF) to a Hold

David Low

UBS

$1,285.52

Hold

-46.24%

Downside

Reiterated

07/15/26

Cochlear (CHEOF) Gets a Hold from UBS

Laura Sutcliffe

Citi

$1,152.12→$1,212.75

Sell

-49.29%

Downside

Reiterated

07/13/26

Citi Remains a Sell on Cochlear (CHEOF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$1,867.64→$1,612.96

Hold

-32.55%

Downside

Reiterated

07/02/26

Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$1,394.67→$1,443.18

Hold

-39.65%

Downside

Reiterated

06/30/26

Macquarie Remains a Hold on Cochlear (CHEOF)

Shane Storey

Canaccord Genuity

$3,577.62→$1,455.3

Buy

-39.14%

Downside

Reiterated

04/29/26

Canaccord Genuity Reaffirms Their Buy Rating on Cochlear (CHEOF)

David Bailey

Morgan Stanley

$2,352.74→$1,443.18

Hold

-39.65%

Downside

Upgraded

04/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Cochlear (Other OTC: CHEOF), CervoMed (NASDAQ: CRVO) and Community Health (NYSE: CYH)

Derek Jellinek

Morgans

$2,606.57→$1,299.71

Hold

-45.65%

Downside

Reiterated

04/23/26

Cochlear (CHEOF) Gets a Hold from Morgans

Steven Wheen

Jarden

$2,716.57→$2,049.55

Hold

-14.29%

Downside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

$2,970.03→$2,617.12

Hold

9.44%

Upside

Reiterated

03/13/26

Goldman Sachs Keeps Their Hold Rating on Cochlear (CHEOF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Stanton

Jefferies

$1,557.18

Hold

-34.88%

Downside

Downgraded

07/28/26

Cochlear (CHEOF) was downgraded to a Hold Rating at Jefferies

Chris Cooper

J.P. Morgan

$1,346.16→$1,448.03

Hold

-39.45%

Downside

Reiterated

07/21/26

Cochlear (CHEOF) Receives a Hold from J.P. Morgan

Craig Wong-Pan

RBC Capital

$1,515.94→$1,418.92

Hold

-40.67%

Downside

Downgraded

07/16/26

RBC Capital downgrades Cochlear (CHEOF) to a Hold

David Low

UBS

$1,285.52

Hold

-46.24%

Downside

Reiterated

07/15/26

Cochlear (CHEOF) Gets a Hold from UBS

Laura Sutcliffe

Citi

$1,152.12→$1,212.75

Sell

-49.29%

Downside

Reiterated

07/13/26

Citi Remains a Sell on Cochlear (CHEOF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$1,867.64→$1,612.96

Hold

-32.55%

Downside

Reiterated

07/02/26

Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$1,394.67→$1,443.18

Hold

-39.65%

Downside

Reiterated

06/30/26

Macquarie Remains a Hold on Cochlear (CHEOF)

Shane Storey

Canaccord Genuity

$3,577.62→$1,455.3

Buy

-39.14%

Downside

Reiterated

04/29/26

Canaccord Genuity Reaffirms Their Buy Rating on Cochlear (CHEOF)

David Bailey

Morgan Stanley

$2,352.74→$1,443.18

Hold

-39.65%

Downside

Upgraded

04/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Cochlear (Other OTC: CHEOF), CervoMed (NASDAQ: CRVO) and Community Health (NYSE: CYH)

Derek Jellinek

Morgans

$2,606.57→$1,299.71

Hold

-45.65%

Downside

Reiterated

04/23/26

Cochlear (CHEOF) Gets a Hold from Morgans

Steven Wheen

Jarden

$2,716.57→$2,049.55

Hold

-14.29%

Downside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), West Pharmaceutical Services (NYSE: WST) and Cochlear (Other OTC: CHEOF)

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

$2,970.03→$2,617.12

Hold

9.44%

Upside

Reiterated

03/13/26

Goldman Sachs Keeps Their Hold Rating on Cochlear (CHEOF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

3 Months

Shane StoreyCanaccord Genuity

Success Rate

5/9 ratings generated profit

Average Return

-3.96%

Copying Shane Storey's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of -3.96% per trade.

1 Year

Shane StoreyCanaccord Genuity

Success Rate

2/9 ratings generated profit

Average Return

-21.12%

Copying Shane Storey's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -21.12% per trade.

2 Years

Shane StoreyCanaccord Genuity

Success Rate

2/9 ratings generated profit

Average Return

-23.28%

Copying Shane Storey's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -23.28% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

COHN Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, COHN has received 0 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. COHN average Analyst price target in the past 3 months is 1,425.50.

Each month's total comprises the sum of three months' worth of ratings.

COHN Financial Forecast

COHN Earnings Forecast

Next quarter’s earnings estimate for COHN is $20.79 with a range of $14.74 to $23.05. The previous quarter’s EPS was $36.15. COHN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 43.75% of the time in the same period. In the last calendar year COHN has Performed in-line its overall industry.

COHN Sales Forecast

Next quarter’s sales forecast for COHN is $14.22B with a range of $13.69B to $14.89B. The previous quarter’s sales results were $14.26B. COHN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 55.56% of the time in the same period. In the last calendar year COHN has Performed in-line its overall industry.

COHN Stock Forecast FAQ

What is MX:COHN’s average 12-month price target, according to analysts?

Based on analyst ratings, Cochlear Limited’s 12-month average price target is 1,425.50.

What is MX:COHN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for MX:COHN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cochlear Limited a Buy, Sell or Hold?

Cochlear Limited has a consensus rating of Hold, which is based on 0 buy ratings, 6 hold ratings and 1 sell ratings.

What is Cochlear Limited’s share price target?

The average share price target for Cochlear Limited is 1,425.50. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $1,612.96 ,and the lowest forecast is $1,212.75. The average share price target represents -40.39% Decrease from the current price of $2,391.38.

What do analysts say about Cochlear Limited?

Cochlear Limited’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Cochlear Limited?

To buy shares of MX:COHN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cochlear (COHN) Stock Forecast & Price Target

COHN Analyst Ratings

COHN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cochlear

COHN Analyst Recommendation Trends

COHN Financial Forecast

COHN Earnings Forecast

COHN Sales Forecast

COHN Stock Forecast FAQ

Detailed List of Analyst Forecasts